The Michael E. DeBakey VA Medical Center and Baylor College of Medicine are seeking female veterans with post-traumatic stress disorder for a study that might hopefully lead to a new medical treatment for the condition.
The study is aimed at the role played by a neuropeptide called corticotropin-releasing factor (CRF) in causing PTSD symptoms, according to a press release from the DeBakey center.
"It is believed that varying levels of CRF in the brain have an effect on the stress symptoms experienced by those suffering from PTSD," according to the press release. "This is likely because abnormal levels of CRF also result in abnormal levels of chatecholamines and cortisol."
The release also states that "studies have shown women are two times more likely to have PTSD than men" and points out that "treatment options currently available for PTSD are limited. The most common and effective treatment involves a combination of talk therapy and psychotropic medications, such as anti-anxiety and antidepressant medications. With information about CRF and PTSD symptoms, researchers are trying to develop medications that incorporate these findings."
The six-week study involves "taking an investigational drug to change CRF levels."
If you like this story, consider signing up for our email newsletters.
SHOW ME HOW
You have successfully signed up for your selected newsletter(s) - please keep an eye on your mailbox, we're movin' in!
If you're interested, please call the research team at 1-877-96-BCM-MOOD (226-6663) or e-mail firstname.lastname@example.org.